![Megan Baldwin](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Megan Baldwin
Direktor/Vorstandsmitglied bei
RACURA ONCOLOGY LTD
Vermögen: 1 646 $ am 31.07.2026
Profil
Megan Baldwin was the founder of Opthea Ltd., founded in 1984, and served as Chief Innovation Officer from 2024 to 2025.
Current jobs include Deputy Chairman at AusBiotech Ltd. since 2017, Director at Anaxis Pharma Pty Ltd., Director at Gertrude Biomedical Pty Ltd., Independent Non-Executive Director at Racura Oncology Ltd. starting in 2025, and Member at the Australian Institute of Co. Directors.
Former jobs include Chief Executive Officer at Opthea Pty Ltd. from 2012 to 2015, Independent Non-Executive Director at Invex Therapeutics Ltd. from 2021 to 2024, and Member at Roche Group Pty Ltd. Education includes a doctorate from the University of Melbourne.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.09.2025 | 195’299 ( 0.01% ) | 1 646 $ | 31.07.2026 | |
RACURA ONCOLOGY LTD -.--% | 25.11.2025 | 0 ( -.--% ) | - $ | 31.07.2026 |
Aktive Positionen von Megan Baldwin
| Unternehmen | Position | Beginn |
|---|---|---|
| RACURA ONCOLOGY LTD | Direktor/Vorstandsmitglied | 01.01.2025 |
Australian Institute of Co. Directors
 Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Corporate Officer/Principal | - |
AusBiotech Ltd.
 AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Direktor/Vorstandsmitglied | 14.12.2017 |
Anaxis Pharma Pty Ltd.
 Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Megan Baldwin
| Unternehmen | Position | Ende |
|---|---|---|
| CERYVYN THERAPEUTICS LIMITED | Vorstandsvorsitzender | 27.10.2023 |
| INVEX THERAPEUTICS LTD | Direktor/Vorstandsmitglied | 30.06.2024 |
Opthea Pty Ltd. | Vorstandsvorsitzender | 01.12.2015 |
Roche Group Pty Ltd. | Corporate Officer/Principal | - |
Ausbildung von Megan Baldwin
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
66
Beziehungen ersten Grades
9
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 9 |
|---|---|
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
University of Melbourne
 University of Melbourne Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Australian Institute of Co. Directors
Australian Institute of Co. Directors Miscellaneous Commercial ServicesCommercial Services Promotes governance and develops leadership skills | Commercial Services |
AusBiotech Ltd.
AusBiotech Ltd. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology membership company | Commercial Services |
Roche Group Pty Ltd. | |
Opthea Pty Ltd. | |
Race Oncology Ltd.
 Race Oncology Ltd. Pharmaceuticals: MajorHealth Technology Manufactures drugs for cancer | Health Technology |
Invex Therapeutics Ltd.
 Invex Therapeutics Ltd. BiotechnologyHealth Technology Operates as a biopharmaceutical company and develops therapeutics for neurological conditions | Health Technology |
Anaxis Pharma Pty Ltd.
Anaxis Pharma Pty Ltd. BiotechnologyHealth Technology Provides biotechnology and healthcare services | Health Technology |
